The treatment of Cataracts & Palmar Psoriasis with vitamins

Cataracts and Palmar Psoriasis: Mitamins custom make quality formulas for the treatment of Cataracts & Palmar Psoriasis with vitamins. A Cataracts & Palmar Psoriasis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and Palmar Psoriasis

  • Amount Per Serving
    % DV
    Vitamin A
    5000
    IU
    100%
    Vitamin C
    500
    mg
    833%
    Vitamin D
    200
    IU
    50%
    Vitamin E
    100
    IU
    333%
    Riboflavin
    75
    mg
    4412%
    Folate
    400
    mcg
    100%
    Selenium
    200
    mcg
    286%
  • Amount Per Serving
    % DV
    Alpha Lipoic Acid
    50
    mg
    *
    Omega - 3 Fatty Acids
    1000
    mg
    *
    Lutein
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cataracts and Palmar Psoriasis
Serving Size:4-5

Cataracts and Palmar Psoriasis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
'Re-Educating' Immune System Cells Slows Tumour Growth, UK
Immune system cells recruited by cancers to help them grow and spread could be 're-educated' to attack the tumours instead of aiding them, Cancer Research UK scientists announced at the National Cancer Research Institute (NCRI) Conference in Birmingham today.
New Psoriasis Drug Shows Promising Results Say Johnson And Johnson
Centocor Inc, a subsidiary of drug company Johnson & Johnson have announced that international phase 3 trials for its injectable biologic drug to treat psoriasis, CNT0 1275 (ustekinumab), have shown promising results.According to the National Institutes of Health, some 7.5 million Americans have psoriasis, a non-contagious, lifelong skin disease.
This information concerning the support of Cataracts and Palmar Psoriasis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments